SM
KBIO

Sabby Management’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Sabby Management’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-10,081
Closed -$356K – 323
2013
Q4 		$356K Sell
10,081
-3,095
-23% -$104K 0.02% 164
2013
Q3 		$476K Buy
+13,176
New +$600K 0.03% 157

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sabby Management's KBIO Position: Q1 2014 in Review

Sabby Management sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2014, closing a stake of 10,081 shares — an estimated $356K sold.

Sabby Management first reported a position in KBIO in Q3 2013 and held it in 2 quarters. The position peaked at $476K in Q3 2013. 48 funds tracked by Wall St. Rank hold KBIO as of Q1 2014.

  • Sabby Management reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2014 after selling out during the quarter.
  • Sabby Management sold 10,081 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2014, an estimated $356K.
  • Sabby Management first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q3 2013 and held it in 2 quarters.
  • Sabby Management's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $476K in Q3 2013.
  • 48 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2014.

Based on Sabby Management's 13F filing for Q1 2014, filed 14 May 2014.